Streetbeat News

Products Services

DOCS

The healthcare sector is evolving with technology and innovation, focusing on patient-centric approaches. The article suggests three healthcare stocks to consider before 2025.

Portfolio Pulse from

December 16, 2024 | 9:15 pm

AVGO

NVDA

Broadcom Inc. has successfully integrated VMware, significantly reducing operating expenses and boosting margins. The company reported strong Q4 2024 results with 51% YoY revenue growth and EPS beating estimates. Broadcom's entry into the AI accelerator market positions it as a strong competitor against Nvidia, with AI-related sales up 220% in Q4.

Portfolio Pulse from

December 16, 2024 | 9:00 pm

TOL

Toll Brothers, Inc. (NYSE:TOL) announced a new master-planned community, Overbrook Estates, in Huntersville, North Carolina. Construction will start in early spring 2025, with sales beginning in late spring 2025.

Portfolio Pulse from

December 16, 2024 | 9:00 pm

ADI

Analog Devices, a leading semiconductor company, is well-positioned in high-growth areas like automotive and industrial markets. The company is expected to recover from end-market downturns by FY25, supported by strong R&D investments and partnerships.

Portfolio Pulse from

December 16, 2024 | 9:00 pm

ABBV

AbbVie presents a strong investment opportunity following a recent price drop, offering dividend income, value, and growth potential. The company's robust drug portfolio, including Skyrizi and Rinvoq, supports its long-term prospects. AbbVie's solid balance sheet and consistent dividend growth make it attractive for investors.

Portfolio Pulse from

December 16, 2024 | 8:45 pm

ACN

Accenture is expected to report $3.42 EPS on $17.14B in revenues for Q1, with potential to beat estimates. The company is expanding in AI, aiming for 80,000 AI-focused employees by FY26, but there are concerns about AI investments and M&A-driven growth.

Portfolio Pulse from

December 16, 2024 | 8:45 pm

BIOA

BioAge Labs, Inc. is under investigation by Levi & Korsinsky for potential securities law violations after discontinuing its STRIDES Phase 2 trial for azelaprag due to safety concerns.

Portfolio Pulse from

December 16, 2024 | 8:45 pm

ABNB

AMZN

TSLA

The article discusses top stock picks for 2025, highlighting Amazon (AMZN), Tesla (TSLA), and Airbnb (ABNB) as key players expected to benefit from the growing momentum of artificial intelligence in the coming years.

Portfolio Pulse from

December 16, 2024 | 8:30 pm

FUTY

With rising geopolitical tensions and inflation concerns in the U.S., investors are advised to increase exposure to defensive sectors through ETFs to navigate potential economic uncertainties in 2025.

Portfolio Pulse from

December 16, 2024 | 8:30 pm

HOMZ

The article discusses the potential stability of the housing market in 2025 and suggests that investing in certain ETFs could be favorable. It hints at the possibility of HOMZ being one of the ETFs to consider.

Portfolio Pulse from

December 16, 2024 | 8:30 pm